Health Technology Assessment World Europe 2014

Topics

• The latest HTA (Health Technology Assessment) requirements from different HTA authorities across Europe
• Developments in early dialogue / scientific advice for companies
• Implications of value based pricing and how to plan for implementation
• How global healthcare reforms are impacting HTA and market access
• Patient involvement in evidence development and HTA decision making

Who should Attend

Attendees from pharmaceutical companies and Health Technology Assessment agencies from across the world.